Incidence of persistent and high-risk human papillomavirus infection and associated factors among HIV-positive women in China, 2015–2016

[1]  L. Fang,et al.  High-risk Human Papillomavirus Infection and Associated Factors among HIV-positive Women in High HIV-burden Areas of China. , 2020, Biomedical and environmental sciences : BES.

[2]  W. Guo,et al.  [Spatial-temporal distribution of newly detected HIV/AIDS cases among aged 15 years or older women in China, 2010-2016]. , 2018, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[3]  Zhengrong Sun,et al.  Prevalence of microorganisms co-infections in human papillomaviruses infected women in Northern China , 2016, Archives of Gynecology and Obstetrics.

[4]  Yong Jiang,et al.  The diversity of human papillomavirus infection among human immunodeficiency virus-infected women in Yunnan, China , 2014, Virology Journal.

[5]  H. Bao,et al.  Multiple microRNAs targeted to internal ribosome entry site against foot-and-mouth disease virus infection in vitro and in vivo , 2014, Virology Journal.

[6]  Congjian Xu,et al.  Risk factors for human papillomavirus infection in Shanghai suburbs: a population-based study with 10,000 women. , 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[7]  D. Larsimont,et al.  Sustained viral suppression and higher CD4+ T-cell count reduces the risk of persistent cervical high-risk human papillomavirus infection in HIV-positive women. , 2013, The Journal of infectious diseases.

[8]  D. Larsimont,et al.  High-risk human papillomavirus infection in HIV-positive African women living in Europe , 2013, Journal of the International AIDS Society.

[9]  H. Cai,et al.  Epidemiologic risk profile of human papillomavirus infections in human immunodeficiency virus-positive Chinese women. , 2011, Japanese journal of infectious diseases.

[10]  丁岩,et al.  新疆维吾尔族生殖道高危型人乳头瘤病毒感染相关危险因素的分析及分型 , 2011 .

[11]  X. Gui,et al.  Cancer in cohort of HIV-infected population: prevalence and clinical characteristics , 2011, Journal of Cancer Research and Clinical Oncology.

[12]  F. Buonaguro,et al.  Human papillomavirus (HPV) genotypes and HPV16 variants in human immunodeficiency virus-positive Italian women. , 2008, The Journal of general virology.

[13]  Martyn Plummer,et al.  International Correlation between Human Papillomavirus Prevalence and Cervical Cancer Incidence , 2008, Cancer Epidemiology Biomarkers & Prevention.

[14]  C. Lin,et al.  Patients with malignant or pre-malignant cervical lesion have increased risk of becoming hepatitis B carrier. , 2007, Journal of experimental & clinical cancer research : CR.

[15]  David R. Scott,et al.  The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. , 2005, Journal of the National Cancer Institute.

[16]  J. Peto,et al.  Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort , 2004, British Journal of Cancer.

[17]  C J L M Meijer,et al.  The causal relation between human papillomavirus and cervical cancer. , 2002, Journal of clinical pathology.

[18]  M. Chiasson,et al.  HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: a prospective cohort study , 2002, The Lancet.

[19]  L. Ahdieh,et al.  Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. , 2001, The Journal of infectious diseases.

[20]  J. Goedert,et al.  Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. , 2000, Journal of the National Cancer Institute.

[21]  Y. Qiao,et al.  HPV prevalence and cervical intraepithelial neoplasia among HIV-infected women in Yunnan Province, China: a pilot study. , 2012, Asian Pacific journal of cancer prevention : APJCP.